publication venue for Antipsychotic drug effects on brain morphology in first-episode psychosis.. 62:361-370. 2005 A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.. 60:1218-1226. 2003 Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.. 60:1079-1088. 2003 Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia.. 59:321-331. 2002 Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.. 59:233-239. 2002 Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.. 59:62-69. 2002 Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.. 57:841-849. 2000 Maintenance treatment in bipolar disorder.. 57:490-492. 2000 First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe.. 55:173-180. 1998 Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.. 54:49-55. 1997 Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.. 51:98-108. 1994 Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.. 50:448-455. 1993 Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.. 48:1082-1088. 1991 Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis.. 47:1106-1111. 1990 The effects of insurance generosity on the psychological distress and psychological well-being of a general population.. 46:315-320. 1989 Changes in popular attitudes and beliefs about tranquilizers. 1970-1979.. 43:527-532. 1986 Lack of preference for diazepam in anxious volunteers.. 43:533-541. 1986 Insomnia and its treatment. Prevalence and correlates.. 42:225-232. 1985 Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use.. 40:1167-1173. 1983 Cognitive dysfunction and imipramine in outpatient depressive.. 38:1048-1051. 1981 Psychiatric screening in a medical clinic. An evaluation of a self-report inventory.. 35:1189-1195. 1978 Minor tranquilizers: clinical correlates of use in an urban population.. 35:650-655. 1978 Symptom intensity and life stress in the city.. 31:759-764. 1974 Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo.. 30:106-111. 1974 Symptom configuration and life events.. 28:744-748. 1973 Symptom intensity and life events.. 28:473-477. 1973 Predicting the relief of anxiety with meprobamate. An attempt at replication.. 26:85-91. 1972 Scaling of life events.. 25:340-347. 1971 Factors of symptom distress. Doctor ratings of anxious neurotic outpatients.. 21:328-338. 1969 Predicting the relief of anxiety with meprobamate. Nondrug factors in the response of psychoneurotic outpatients.. 19:619-630. 1968 Subjective change with medical student therapists. II. Some determinants of change in psychoneurotic outpatients.. 18:532-540. 1968 Subjective change with medical student therapists. I. Course of relief in psychoneurotic outpatients.. 18:428-438. 1968